Psychiatry Research
Volume 105, Issue 1 , Pages 117-121 , 15 December 2001

Plasma testosterone and pathological gambling

  • Carlos Blanco

      Affiliations

    • Department of Psychiatry, Columbia University and New York State Psychiatric Institute, 1051 Riverside Drive, Box 69, New York, NY 10032, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-212-543-6533; fax: +1-212-543-6515
    • ,
  • Angela Ibáñez

      Affiliations

    • Department of Psychiatry, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Carmen-Rosa Blanco-Jerez

      Affiliations

    • Department of Biochemical Research, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Enrique Baca-Garcia

      Affiliations

    • Department of Psychiatry, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Jerónimo Sáiz-Ruiz

      Affiliations

    • Department of Psychiatry, Hospital Ramón y Cajal, Madrid, Spain

Received 25 August 2000 ,Revised 2 May 2001 ,Accepted 4 June 2001.

References 

  1. American Psychiatric Association . In: DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  2. Archer J. The influence of testosterone on human aggression. British Journal of Psychology. 1991;82:1–28
  3. Blanco C, Orensanz Munoz L, Blanco Jerez CR, Sáiz-Ruiz J. Pathological gambling and MAO activity: a psychobiological study. American Journal of Psychiatry. 1996;153:119–121
  4. Blanco C, Petkova E, Ibáñez A, Sáiz-Ruiz J. A long-term, double-blind, placebo-controlled study of fluvoxamine for the treatment of pathological gambling. Presented at the 152nd Annual Meeting of the American Psychiatric Association, Washington, DC; 1999;
  5. Blaszczynski A, Steel Z, McConaghy N. Impulsivity in pathological gambling: the antisocial impulsivist. Addiction. 1997;92:75–87
  6. Brooks JH, Reddon JR. Serum testosterone in violent and nonviolent young offenders. Journal of Clinical Psychology. 1996;52:475–483
  7. Dabbs JM. Testosterone measurements in social and clinical psychology. Journal of Social and Clinical Psychology. 1992;11:302–321
  8. DeCaria C, Hollander E, Nora R, Stein D, Simeon D, Cohen L. Gambling: biological/genetic, treatment, government, and gambling concerns. Neurobiology of pathological gambling. Presented at the 150th Annual Meeting of the American Psychiatric Association, San Diego, CA; 1997;
  9. Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Questionnaire. London: Hodder & Stoughton; 1975;
  10. Gossop NK, Eysenck SBG. A further investigation into the personality of drug addicts in treatment. British Journal of Addiction. 1980;75:305–311
  11. Higley JD, Mehlman PT, Poland RE, Taub DM, Vickers J, Suomi SJ, et al. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biological Psychiatry. 1996;40:1067–1082
  12. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley & Sons; 1972;
  13. Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. American Journal of Psychiatry. 1999;155:1781–1783
  14. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biological Psychiatry. 2000;47:813–817
  15. Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, Blanco C, Sáiz-Ruiz J. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Molecular Psychiatry. 2000;5:105–109
  16. Lesieur HR, Rosenthal RJ. Pathological gambling: a review of the literature. Journal of Gambling Studies. 1991;7:5–40
  17. Mann JJ, Malone K. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biological Psychiatry. 1997;41:162–171
  18. McCormick RA, Taber J, Kruedelbach N, Russo A. Personality profiles of hospitalized pathological gamblers: the California Personality Inventory. Journal of Clinical Psychology. 1987;43:521–527
  19. Moreno I, Sáiz-Ruiz J, Lopez-Ibor JJ, Aliño JJ. Serotonin and gambling dependence. Human Psychopharmacology. 1991;6:S9–S12
  20. Neter J, Kutner MH, Nachstein CJ, Wasserman W. In: Applied Linear Regression Models. 3rd ed.. Chicago: Irwin; 1996;
  21. Pérez de Castro I, Ibañez A, Sáiz-Ruiz J, Fernández-Piqueras J. Genetic contribution to pathological gambling: association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics. 1999;9:397–400
  22. Rasanen P, Hakko H, Visuri S, Paanila J, Kapanen P, Suomela T, et al. Serum testosterone levels, mental disorders and criminal behaviour. Acta Psychiatrica Scandinavica. 1999;99:348–352
  23. Rugle L, Melamed L. Neuropsychological assessment of attention problems in pathological gamblers. Journal of Nervous and Mental Disease. 1993;181:107–112
  24. Stålenheim EG, Eriksson E, von Knorring L, Wide L. Testosterone as a biological marker in psychopathy and alcoholism. Psychiatry Research. 1998;77:79–88
  25. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Archives of General Psychiatry. 1994;51:20–27

PII: S0165-1781(01)00333-X

Psychiatry Research
Volume 105, Issue 1 , Pages 117-121 , 15 December 2001

Article Tools